165 related articles for article (PubMed ID: 23478312)
1. Natural cannabinoids improve dopamine neurotransmission and tau and amyloid pathology in a mouse model of tauopathy.
Casarejos MJ; Perucho J; Gomez A; Muñoz MP; Fernandez-Estevez M; Sagredo O; Fernandez Ruiz J; Guzman M; de Yebenes JG; Mena MA
J Alzheimers Dis; 2013; 35(3):525-39. PubMed ID: 23478312
[TBL] [Abstract][Full Text] [Related]
2. Trehalose ameliorates dopaminergic and tau pathology in parkin deleted/tau overexpressing mice through autophagy activation.
Rodríguez-Navarro JA; Rodríguez L; Casarejos MJ; Solano RM; Gómez A; Perucho J; Cuervo AM; García de Yébenes J; Mena MA
Neurobiol Dis; 2010 Sep; 39(3):423-38. PubMed ID: 20546895
[TBL] [Abstract][Full Text] [Related]
3. Suppression of Parkin enhances nigrostriatal and motor neuron lesion in mice over-expressing human-mutated tau protein.
Menéndez J; Rodríguez-Navarro JA; Solano RM; Casarejos MJ; Rodal I; Guerrero R; Sánchez MP; Avila J; Mena MA; de Yébenes JG
Hum Mol Genet; 2006 Jul; 15(13):2045-58. PubMed ID: 16698879
[TBL] [Abstract][Full Text] [Related]
4. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
[TBL] [Abstract][Full Text] [Related]
5. Parkin deletion causes cerebral and systemic amyloidosis in human mutated tau over-expressing mice.
Rodríguez-Navarro JA; Gómez A; Rodal I; Perucho J; Martinez A; Furió V; Ampuero I; Casarejos MJ; Solano RM; de Yébenes JG; Mena MA
Hum Mol Genet; 2008 Oct; 17(20):3128-43. PubMed ID: 18640988
[TBL] [Abstract][Full Text] [Related]
6. Sativex-like combination of phytocannabinoids is neuroprotective in malonate-lesioned rats, an inflammatory model of Huntington's disease: role of CB1 and CB2 receptors.
Valdeolivas S; Satta V; Pertwee RG; Fernández-Ruiz J; Sagredo O
ACS Chem Neurosci; 2012 May; 3(5):400-6. PubMed ID: 22860209
[TBL] [Abstract][Full Text] [Related]
7. Hyperexcitability and epileptic seizures in a model of frontotemporal dementia.
García-Cabrero AM; Guerrero-López R; Giráldez BG; Llorens-Martín M; Avila J; Serratosa JM; Sánchez MP
Neurobiol Dis; 2013 Oct; 58():200-8. PubMed ID: 23774255
[TBL] [Abstract][Full Text] [Related]
8. Effects of a Sativex-Like Combination of Phytocannabinoids on Disease Progression in R6/2 Mice, an Experimental Model of Huntington's Disease.
Valdeolivas S; Sagredo O; Delgado M; Pozo MA; Fernández-Ruiz J
Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28333097
[TBL] [Abstract][Full Text] [Related]
9. Neurodegenerative disorder FTDP-17-related tau intron 10 +16C → T mutation increases tau exon 10 splicing and causes tauopathy in transgenic mice.
Umeda T; Yamashita T; Kimura T; Ohnishi K; Takuma H; Ozeki T; Takashima A; Tomiyama T; Mori H
Am J Pathol; 2013 Jul; 183(1):211-25. PubMed ID: 23680655
[TBL] [Abstract][Full Text] [Related]
10. A Sativex(®) -like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosis.
Feliú A; Moreno-Martet M; Mecha M; Carrillo-Salinas FJ; de Lago E; Fernández-Ruiz J; Guaza C
Br J Pharmacol; 2015 Jul; 172(14):3579-95. PubMed ID: 25857324
[TBL] [Abstract][Full Text] [Related]
11. Effects of alpha-tocopherol on an animal model of tauopathies.
Nakashima H; Ishihara T; Yokota O; Terada S; Trojanowski JQ; Lee VM; Kuroda S
Free Radic Biol Med; 2004 Jul; 37(2):176-86. PubMed ID: 15203189
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic and preventive effects of methylene blue on Alzheimer's disease pathology in a transgenic mouse model.
Paban V; Manrique C; Filali M; Maunoir-Regimbal S; Fauvelle F; Alescio-Lautier B
Neuropharmacology; 2014 Jan; 76 Pt A():68-79. PubMed ID: 23891615
[TBL] [Abstract][Full Text] [Related]
13. [Animal models of tauopathies].
Higuchi M
Rinsho Shinkeigaku; 2006 Nov; 46(11):928-30. PubMed ID: 17432223
[TBL] [Abstract][Full Text] [Related]
14. Hippocampal tauopathy in tau transgenic mice coincides with impaired hippocampus-dependent learning and memory, and attenuated late-phase long-term depression of synaptic transmission.
Van der Jeugd A; Ahmed T; Burnouf S; Belarbi K; Hamdame M; Grosjean ME; Humez S; Balschun D; Blum D; Buée L; D'Hooge R
Neurobiol Learn Mem; 2011 Mar; 95(3):296-304. PubMed ID: 21167950
[TBL] [Abstract][Full Text] [Related]
15. The effects of lignan-riched extract of Shisandra chinensis on amyloid-β-induced cognitive impairment and neurotoxicity in the cortex and hippocampus of mouse.
Jeong EJ; Lee HK; Lee KY; Jeon BJ; Kim DH; Park JH; Song JH; Huh J; Lee JH; Sung SH
J Ethnopharmacol; 2013 Mar; 146(1):347-54. PubMed ID: 23333311
[TBL] [Abstract][Full Text] [Related]
16. Elevated levels of soluble total and hyperphosphorylated tau result in early behavioral deficits and distinct changes in brain pathology in a new tau transgenic mouse model.
Flunkert S; Hierzer M; Löffler T; Rabl R; Neddens J; Duller S; Schofield EL; Ward MA; Posch M; Jungwirth H; Windisch M; Hutter-Paier B
Neurodegener Dis; 2013; 11(4):194-205. PubMed ID: 22797329
[TBL] [Abstract][Full Text] [Related]
17. Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits.
Schindowski K; Bretteville A; Leroy K; Bégard S; Brion JP; Hamdane M; Buée L
Am J Pathol; 2006 Aug; 169(2):599-616. PubMed ID: 16877359
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of fruits of Morinda citrifolia L. on scopolamine induced memory impairment in mice: a behavioral, biochemical and cerebral blood flow study.
Pachauri SD; Tota S; Khandelwal K; Verma PR; Nath C; Hanif K; Shukla R; Saxena JK; Dwivedi AK
J Ethnopharmacol; 2012 Jan; 139(1):34-41. PubMed ID: 22107832
[TBL] [Abstract][Full Text] [Related]
19. Sex difference in pathology and memory decline in rTg4510 mouse model of tauopathy.
Yue M; Hanna A; Wilson J; Roder H; Janus C
Neurobiol Aging; 2011 Apr; 32(4):590-603. PubMed ID: 19427061
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of CB2 cannabinoid receptors results in neuroprotection against behavioral and neurochemical alterations induced by intracaudate administration of 6-hydroxydopamine.
Ternianov A; Pérez-Ortiz JM; Solesio ME; García-Gutiérrez MS; Ortega-Álvaro A; Navarrete F; Leiva C; Galindo MF; Manzanares J
Neurobiol Aging; 2012 Feb; 33(2):421.e1-16. PubMed ID: 20980074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
